Glaxo Says Covid-19 Antibody Drug Works Against Omicron – Community News
Covid-19

Glaxo Says Covid-19 Antibody Drug Works Against Omicron

GlaxoSmithKline PLC and Vir Biotechnology Inc. said their treatment with Covid-19 antibodies retained effectiveness against the Omicron variant in lab studies, even as early data suggests similar treatments may not work as well against the highly mutated strain.

The results offer hope that at least one monoclonal antibody therapy — a form of treatment that has been shown to be helpful in attenuating serious diseases — will remain effective against Omicron, which has been detected in dozens of countries, including the US since it was identified by scientists in the South. -America. Africa two weeks ago.